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Abstract
Backgroud: Extramedullary hematopoiesis (EMH) is defined as the presence of hematopoietic stem cells such as
erythroid and myeloid lineage plus megakaryocytes in extramedullary sites like liver, spleen and lymph nodes and
is usually associated with either bone marrow or hematological disorders. Mammary EMH is a rare condition either
in human and veterinary medicine and can be associated with benign mixed mammary tumors, similarly to that
described in this case.
Case presentation: Hematopoietic stem cells were found in a benign mixed mammary tumor of a 7-year-old
female mongrel dog that presents a nodule in the left inguinal mammary gland. The patient did not have any
hematological abnormalities. Cytological evaluation demonstrated two distinct cell populations, composed of either
epithelial or mesenchymal cells, sometimes associated with a fibrillar acidophilic matrix, apart from megakaryocytes,
osteoclasts, metarubricytes, prorubricytes, rubricytes, rubriblasts, promyelocytes, myeloblasts. Histological
examination confirmed the presence of an active hematopoietic bone marrow within the bone tissue of a benign
mammary mixed tumor.
Conclusions: EMH is a rare condition described in veterinary medicine that can be associated with mammary
mixed tumors. It’s detection can be associated with several neoplastic and non-neoplastic mammary lesions, i.e.
osteosarcomas, mixed tumors and bone metaplasia.
Background
Hematopoiesis in the adult animal is restricted to the
marrow cavity of flat bones and long bones epiphysis
[1]. Thus, extramedullary hematopoiesis (EMH) is
defined as the presence of hematopoietic stem cells such
as erythroid and myeloid lineage plus megakaryocytes in
extramedullary sites and is usually associated with either
bone marrow or hematological disorders [1-4]. Despite
the fact that extramedullary hematopoieses can occur in
any organ, it is more frequently seen in liver, spleen and
lymph nodes [3-8].
Mammary EMH is a rare condition and it is generally
associated with non-neoplastic hematopoietic masses in
both woman and bitches. However, the presence of
hematopoietic activity can also be seen as an incidental
finding associated with mammary neoplasia [2,4,9-12].
Cytological examination has been used since the 60’s
to investigate mammary lesions in women, and it is
nowadays largely accepted as a screening test for such
lesions in veterinary medicine. It is a minimally invasive
and low cost diagnostic method which allows differen-
tiation between non-neoplastic and neoplastic mammary
lesions. In addition, it can accurately predict the malig-
nant potential of mammary tumors if performed by an
experienced pathologist [13-18].
Based upon prevailing cytological characteristics,
canine mammary tumors can be classified as epithelial,
mesenchymal, or mixed type according to its origin
[13,18].
Proliferation of epithelial cells from ducts and/or
lobes, myoepithelial, and mesenchymal cells, in addition
to cartilaginous, bone or myxoid fibrous tissue are
sometimes seen in a variety of mammary neoplasm in
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designation of mixed tumors [11,15,18-20], and repre-
sents up to 50% of the canine mammary tumors
[19,21,22]. In humans, similar mammary lesions are
uncommon, but are frequently seen in salivary glands
[23,24].
Even though the tumor cytological examination may
show considerable tissue heterogeneity [18], hemato-
logical stem cells are seldom observed. Hence, the
o b j e c t i v eo ft h i sc a s er e p o r tw a st od e s c r i b et h ep r e -
sence of hematopoietic stem cells in cytological sam-
ples of a spontaneous mixed benign mammary tumor
in a bitch.
Case presentation
A 7-year-old intact female non-pure breed dog weighing
8.0 kg was admitted at the School of Veterinary Medi-
cine and Animal Science from the Univ. Estadual Pau-
lista (UNESP), Botucatu, São Paulo, Brazil. On clinical
examination it was noted a subcutaneous mass in the
left inguinal mammary gland, measuring 0.7 × 0.9 cm,
and with 24-week of clinical evolution. The lesion was
also firm with a smooth surface, painless, and with no
ulceration nor deep muscle adhesion.
Thoracic radiography, hematological and blood bio-
chemistry analysis, and cytological evaluation of the
lesion were performed in order to achieve a diagnosis.
For cytological analysis, samples were obtained from
2 different areas using a fine needle (22 G1 1/4’’,
Injex®, São Paulo, Brazil) and a 10 ml syringe (Injex®,
São Paulo, Brazil). The collected material was spread
on five histological slides, and then fixed with metha-
nol P.A. (Merck®, Darmstadt, Germany) and ethanol
95% (Merck®, Darmstadt, Germany). Three slides were
stained with Giemsa and two with Papanicolaou stain.
Samples were examined under light microscopy and
classified according to Allen et al. [13] and Raskin
and Meyer [18] standards for neoplastic mammary
lesions.
After routine anesthetic procedures and local antisep-
sis, the animal was submitted to mastectomy. The
tumor was collected, 10% formalin fixed, routinely pro-
cessed and stained with hematoxylin and eosin (H&E).
Then, the samples were analyzed under light
microscopy.
Results of hemogram, blood biochemistry and
radiological examination
Hematological parameters and urea, creatinine, alkaline
phosphatase, aspartate aminotransferase and alanine
aminotransferase values were within reference interval
considered normal for the specie (Table 1). Thorax
radiographic examination did not find any detectable
change.
Results of cytological examination
Cytological evaluation (Figures 1 and 2) revealed high
celullarity composed predominately by a high quantity
of erythrocytes, moderate quantity of metarubricytes
and discrete quantity of megakaryocytes, osteoclasts,
rubricytes, promyelocytes, myeloblasts, prorubricytes
and rubriblasts. Mitotic index was high, with typical
mitosis. It was also seen other two cell populations: the
first was composed by neoplastic epithelial cells
arranged in tridimensional clusters with a moderate and
indistinct basophilic cytoplasm with mild anisocytosis.
Nuclei were oval and hyperchromatic, with mild aniso-
karyosis and indistinct nucleoli. No mitotic figures were
observed; the second cell population was composed by
scattered isolated fusiform cells, sometimes associated
with fibrilar acidophilic matrix with moderate and mild
basophilic cytoplasm. Nuclei were elongate and hyper-
chromatic. Nucleoli were indistinct.
Results of histological analysis
Histopathology revealed (Figure 3) an encapsulated and
heterogeneous neoplasm composed by epithelial cells
arranged in an acinar pattern presenting indistinct eosi-
nophilic homogeneous cytoplasm, with clear vacuoles of
various sizes and discrete anisocytosis. Nuclei were oval
in shape with a loose chromatin pattern, a distinct small
Table 1 Hematological parameters and biochemical
analysis of a female dog with benign mixed mammary
tumor, showing extramedullary hematopoiesis
Parameters Result Reference value ***
Erythrocyte (x10
6/μl) 6.13 5.50-8.50
Hematocrit (%) 40.00 37.00-55.00
Hemoglobin (g/dl) 15.00 12.00-18.00
MCV (pg)* 65.30 60.00-77.00
MCHC (%)** 36.00 32.00-36.00
Total leukocyte (x10
3/μl) 11.20 6.00-17.00
Segmented neutrophils (x10
3/μl) 6.80 3.00-11.50
Rods neutrophils (x10
3/μl) 0.00 0.00-0.30
Eosinophils (x10
3/μl) 0.60 0.10-1.25
Lymphocytes (x10
3/μl) 4.60 1.00-4.80
Monocytes (x10
3/μl) 0.20 0.15-1.35
Platelets (x10
3/μl) 150.00 165.00-460.00
Urea (mg/dl) 30.30 21.40-59.92
Creatinine (mg/dl) 0.90 0.50-1.50
Alkaline phosphatase (UI/l) 87.20 20.00-156.00
Aspartate aminotransferase (UI/l) 11.80 6.20-13.00
Alanine aminotransferase (UI/l) 57.00 21.00-73.00
Total proteins (g/dl) 7.00 5.40-7.10
Albumin (g/dl) 2.70 2.60-3.30
Globulin (g/dl) 4.40 2.70-4.40
*MCV - Mean Corpuscular Volume
**MCHC - Mean Corpuscular Hemoglobin Concentration
***Jain [26].
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Page 2 of 6Figure 1 Photomicrography of fine needle cytology from benign mixed mammary tumor in a non-purebred female dog. Presence of
erythroids and myeloids stem cells associated to a group of neoplastic epithelial cells. Giemsa, 40×.
Figure 2 Photomicrography of fine needle cytology from benign mixed mammary tumor in a non-purebred female dog. Presence of a
megakaryocyte (arrow). Papanicolaou, 40×.
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Page 3 of 6nucleolus and mild anisokaryosis. The myoepithelial
component was composed by cells immersed in a myx-
oid matrix scattered between the acini, with distinct
eosinophilic star-like cytoplasm. Nuclei were elongated
and hyperchromatic with no distinct nucleoli. The
mesenchymal component was composed by cartilage,
bone and fat differentiation. The active bone marrow
was composed by trilineage hematopoietic cells, i.e.
myeloid, erytroid and megakaryocytic precursors. No
mitosis was seen. We could also observe a high quantity
of collagenous stroma.
Discussion
Spontaneous mammary tumors in bitches are very simi-
lar to those in women, which makes it a good model for
comparative studies [14,16] in terms of diagnostic, prog-
nostic, behavioral, morphological, and biological
approaches.
The mixed type, either benign or malignant, is one of
the most common mammary gland tumor in bitches
[19,21,22], unlike humans in which it is uncommon.
However, the last ones have a high frequency of salivary
gland neoplasia, denominated pleomorphic adenomas
[23,24]. Benign mixed mammary tumors in dogs and
pleomorphic adenomas in human salivary glands derive
from exocrine glands that present similar architecture,
and predominantly occur in females. Such tumors have
morphological and molecular similarities which in turn
suggests a similar pathogenic mechanism involved in
malignant transformation [20,24].
The cytological examination usually shows that most
of the pleomorphic adenomas present groups of
epithelial, myoepithelial, and bone tissue cells, as well
a chondromyxoid stroma [23]. Similarly, canine mixed
mammary tumors may present epithelial, fibroblastic,
cartilaginous, bone and rarely hematopoietic compo-
nents. An acidophilic extracellular material, cell-asso-
ciated or not, representing osteoid matrix could also
be present. In addition, there may be various amounts
of erytrocytes, foam cells, basophilic protein material
and lipids on background [11,15,16,18-20]. Despite
this, it is not common to find all these components in
all samples [18] similarly to those described in this
case. However, the representativeness of the lesion was
guaranteed by its size and multiple sampling areas,
which permits an accurate assessment of all neoplasm
cytological components as confirmed later by histologi-
cal analysis.
According to Allen et al. [13], during the cytological
evaluation three or more architectural and/or nuclear
malignancy criteria should be present in order to con-
sider a diagnosis of a malignant tumor. In the present
study, cytological evaluation of cell population on
Giemsa and Papanicolaou stains did not show any of
those criteria thus suggesting a benign tumor. The pos-
sibility of malignant transformation was minimal, since
Figure 3 Photomicrography of histological examination of a benign mixed mammary tumor in a non-purebred female dog. Presence
of hematopoietic active medulla (arrow) inside the neoplasia. Hematoxicilin and Eosin. 10×.
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a multiple sampling technique.
The presence of one of the three lineages of hemato-
poietic cells out of the bone marrow is sufficient to
characterize EMH [3,4]. In this case it was seen, apart
from osteoclasts, some megakaryocytes, erythrocytes and
myeloid lineage cells. These findings are similar to those
described by Fernandes et al., [11] that observed ery-
throcytes and megakaryocytes in a benign mixed mam-
mary tumor in a female dog and similar to the
histological findings reported by Martinelli et al. [2],
Brooks et al. [9], Setsu et al. [10], Cufer and Bracko
[12]. Even before histological confirmation, these cells
were observed in the cytological examination, which
allowed a suggestive diagnosis of benign mixed mam-
mary tumor with a hematopoietic active bone marrow
in a very fast and precocious fashion, as demonstrated
by Allen et al. [13], Hellmén and Lindgren [14], Zuccari
et al. [15], Cassali et al. [16], Simon et al. [17]. However,
cytologic evaluation alone did not permit us to exclude
the diagnosis of a possible bone metaplasia or
osteosarcoma.
EMH is generally seen in patients with bone marrow
and hematological diseases such as chronic anemia,
hematopoietic neoplasia, medular hyperplasia, suppura-
tive bacterial infections, or cardiorespiratory conditions
[1,3,4,8,25]. In such scenario, apart from the spleen,
liver and lymphnodes, there can be microscopic hemato-
poietic areas in kidneys, lungs, gastrointestinal tract,
adrenals, skin, heart, ovaries, epididymides, thymus, peri-
toneum, meninges and breast in humans [2-8], and
choroid plexus and mammary gland in dogs [1,11].
Several hypothesis has been suggested to explain
mammary EMH. Functional disruptions of bone mar-
row, e.g. drug therapy or myelofibrosis, stimulates circu-
lating stem cells to find a favorable environment and
differentiate into hematopoietic cells [4]. Focal lesions
such as biopsies or surgeries are able to induce the pro-
duction of growth factors or cytokines that activate
hematopoiesis [6].
In this case, no biochemical or hematologic changes
that could characterize a functional failure of bone mar-
row were detected, which could result in the production
of chemical mediators capable of promoting favorable
environment for stem cell implantation. The patient
didn’t suffer from any other disease, and was not under
current drug therapy. No previous surgical manipulation
of the mass was attempted. Thus, the pathogenesis of
this case shall probably be related to intrinsic factors of
the neoplastic process.
As far we know there are no reports in human medi-
cine literature regarding the presence of erythrocytes,
myeloids cells, and megakaryocytes in mixed or meta-
plastic breast tumors, and pleomorphic adenomas. In
veterinary medicine there is only one report from Fer-
nandes et al. [11] that reported the presence of two
hematopoietic stem cell lineages in a cytological sample
of a benign mixed mammary tumor in a dog. These
authors did not describe the occurrence of medullar
alterations in their study, making it an incidental finding
just like in this case.
Conclusions
Despite the existence of one previous report, the impor-
tance of those findings relies on the possible relationship
with advanced medullar disorders. Moreover, mammary
EMH is generally asymptomatic and clinically mimics a
neoplasia.
Sampling multiple different sites of the same tumor
mass increases its representativeness and possibility of
an accurate diagnosis, since there is a heterogeneous tis-
sue composition within the same tumor. Hence, the
EMH cytological diagnosis is straightforward when
hematopoietic cells are present. However it’si m p o r t a n t
to emphasize that the simple fact of finding this cell
types does not allow a final diagnosis, since other neo-
plastic and non-neoplastic condition, i.e. osteosarcomas
and bone metaplasia, may present similarly. Despite all
that, histopathological examination is always
recommended.
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